[1] Liu L, Oza S, Hogan D, et al.Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis[J]. Lancet, 2015, 385(9966): 430-440. [2] Su M, Wang Q, Li D, et al.Prevalence and clinical characteristics of hospitalized children with community-acquired Mycoplasma pneumoniae pneumonia during 2017/2018, Chengde, China[J]. Medicine (Baltimore), 2021, 100(5): e23786. [3] Li D, Wang Q, Su M, et al.Molecular Epidemiology and Clinical Features of Haemophilus influenzae among Hospitalized Children with Community-acquired Pneumonia in Chengde, China[J]. Biomed Environ Sci, 2020, 33(8): 623-627. [4] 王倩,苏萌,李丹,等. 333例社区获得性肺炎住院儿童中人偏肺病毒和博卡病毒的分子流行及临床特征[J]. 中华实验和临床病毒学杂志,2019(3):261-266. [5] 刘洪杉,金欣,张楠,等. sTLR2和sTLR4在感染性疾病和自身免疫性疾病中的研究进展[J]. 国际免疫学杂志,2020,43(5):547-552. [6] 陈金妮,李大伟,林秋玉,等. 难治性肺炎患儿感染病原学及HMGB1、TLR2、TLR4表达[J]. 中华医院感染学杂志,2020,30(18):2847-2850. [7] 冯冰瑜,叶洪舟,凌寅杰,等. 外周血TLRs在儿童难治性支原体肺炎临床诊断和预后评估中的应用[J]. 现代实用医学,2021,33(8):1025-1026. [8] 王倩,王毅,杜娈英,等. 重症肺炎支原体肺炎患儿的临床资料及影像学特点分析[J]. 医学理论与实践,2019,32(6):894-896. [9] Yang M, Meng F, Gao M, et al.Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia[J]. Sci Rep, 2019, 9(1): 17853. [10] Esposito S, Droghetti R, Bosis S, et al.Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze[J]. Pediatr Pulmonol, 2002, 34(2): 122-127. [11] Xu XF, Li XJ, Liu JL, et al.Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children[J]. Cytokine, 2016, 86: 73-78. [12] Li M, Chen Y, Li H, et al.Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children[J]. BMC Infect Dis, 2021, 21(1): 909. [13] 谢广成,段招军. 抗病毒感染固有免疫应答的信号转导[J]. 病毒学报,2012,28(3):303-310. [14] 于莉,潘靖丹,杜娈英,等. TLR2和TLR4在抗病毒天然免疫应答中的新作用[J]. 病毒学报,2018,34(4):570-578. [15] Tamiya S, Yoshikawa E, Ogura M, et al.Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1alpha and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice[J]. Microbiol Spectr, 2021, 9(3): e158821. [16] Chen M, Deng H, Zhao Y, et al.Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-alpha Release Mediated by Mycoplasma pneumoniae[J]. Front Cell Infect Microbiol, 2022, 12: 824027. [17] Luo H, He J, Qin L, et al.Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response[J]. Clin Exp Immunol, 2021, 203(1): 66-79. [18] 吴少辉,黄晓冬,徐智航. TLRs信号通路和炎症因子的表达与反复呼吸道感染的关系分析[J]. 中国儿童保健杂志,2021,29(2):205-208. [19] 张新黎,郭昌云. 重症肺炎患者炎症因子水平和TLR2、TLR4的关系研究[J]. 解放军预防医学杂志,2019,37(2):114-115. [20] El-Kharashy G, Gowily A, Okda T, et al.Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer[J]. Mol Clin Oncol, 2021, 14(2): 38. [21] Fakhry N, Gowily A, Okda T, et al.Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma[J]. Contemp Oncol (Pozn), 2020, 24(3): 157-162. [22] Elkammah M, Gowily A, Okda T, et al.Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients[J]. Contemp Oncol (Pozn), 2020, 24(4): 216-220. [23] 李万华. 重症肺炎合并急性肾损伤患者血清TLR4、NF-κB水平变化及其临床意义[J]. 齐齐哈尔医学院学报,2021,42(15):1297-1300. [24] 陈源浩,杨在东,张小芹,等. 血清和肽素、Toll样受体2、Toll样受体4水平与肺炎支原体感染所致重症肺炎患儿的病情、预后的关系探讨[J]. 药物评价研究,2020,43(11):2275-2279. |